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Summary The cellular response. in terms of cell cycle arrest(s) and apoptosis. to radiation-induced DNA
damage was studied. Experiments were performed on both mitogen-stimulated and resting peripheral blood
lymphocytes (PBLs) from normal and cancer-prone (C-P) individuals. The C-P individuals comprised three
patients carrying germline p53 mutations and three members of two families apparently without such
mutations, but with an inherited defect which results in p53 deregulation as shown by high levels of stabilised
p53 protein in normal tissues. Interestingly, mitogen-stimulated PBL, from both normal and C-P individuals
failed to demonstrate a G, arrest after gamma radiation. However, a clear difference was seen in the apoptotic
response to DNA damage, of PBL from normal and C-P individuals; PBLs from C-P individuals with
inherited p53-related defects had a reduced apoptotic response (P = 0.0003). There was a wide margin of
separation, with no overlap between the two groups, supporting the possibility of using this altered apoptotic
response as a screening test. This simple and rapid procedure could be used to identify those individuals in a
C-P family who carry germline p53-related defects. The method appears to detect both individuals with p53
mutations and those apparently without mutations but with other p53-related defects.
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p53 protein was discovered in 1979 by its property of binding
to large T-antigen, the oncogene product of SV40 (Lane and
Crawford, 1979; Linzer and Levine, 1979). In recent years it
has become clear that p53 plays a central role in the cellular
processes involved in recognition of, and response to, DNA
damage. Following a variety of noxious stimuli, such as
gamma or UV irradiation, an accumulation of p53 is seen in
the nuclei of normal cells (Kastan et al., 1991, 1992; Fritsche
et al., 1993; Hall et al., 1993). The precise mechanisms by
which p53 functions at the biochemical level are not yet clear
but the recognition of DNA damage clearly involves more
genes than p53 alone. p53 can act as a transcription factor
for other genes and p53 protein forms complexes with a
considerable number of other proteins. Recently, progress
has been made in understanding the way in which p53
mediates apoptosis in cooperation with transcription factor
E2F-1 (Wu and Levine, 1994). Similarly, recent discoveries
have contributed to the understanding of the mechanism by
which p53 may control cell cycle progression, by controlling
expression of the p21 cyclin-dependent kinase regulator
(Waga et al., 1994). The interactions are clearly complex but
worthy of considerable study given the central role of p53 in
maintaining genetic stability.
Kastan et al. (1991, 1992) and Kuerbitz et al. (1992)
proposed a mechanism by which p53 might act to maintain
genetic stability. They described experiments, in which pro-
liferative cells with wild-type p53 exhibited an arrest of cells
at the G, S boundary following DNA damage. Such a GI
arrest was lost in cells with mutant p53. These workers
suggested that in normal cells the G, arrest might allow time
for damaged cells to repair DNA lesions before entering
S-phase. In cells without functional p53, so this hypothesis
goes, the failure to arrest in G, would lead to the genetic
instability characteristic of tumours, by allowing cells with
damaged DNA to replicate. It is clear, however, that GI
arrest is not the only possible response of normal cells to
DNA damage. Firstly, DNA-damaged cells may not continue
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proliferation at all but rather be deleted via the process of
apoptosis. p53 has been firmly implicated in this process
following the induction of DNA damage (Clark et al., 1993;
Lowe et al., 1993; Ryan et al., 1993). Secondly, it is not
certain that a GI arrest is necessary for the p53 induction of
apoptosis (Hartwell, 1992; Lee and Bernstein, 1993). Yonish-
Rouach et al. (1993), using transfection of p53 deficient
leukaemic cells with a temperature-sensitive mutant p53,
demonstrated that p53-mediated apoptosis did not depend on
G, arrest. Thus questions remain to be answered concerning
the role of G, arrest: namely, is a G, arrest a necessary
response to DNA damage in all cells with functional p53 and
what is the importance of G, arrest in maintaining genetic
stability of cells?
Over the past 25 years a syndrome has been recognised in
which families exhibit a very precise pattern of cancer suscep-
tibility (Li and Fraumeni, 1969; Li et al., 1988) involving
early onset sarcomas, breast carcinoma, lymphoma and
adrenal carcinoma; these families are said to exhibit
Li-Fraumeni syndrome (LFS). In 1990 Malkin et al. demon-
strated a relationship between p53 mutations and LFS. Since
then the situation has become more complex as families with
similar spectra of malignancies have been recognised, which
do not fully meet the precise criteria for recognition as
classical LFS. Such families have been called Li-Fraumeni-
like (LFL) (Birch et al., 1994). Further, even in LFS, germ-
line p53 mutations account for only 50-75% of cases and
for LFL the figure is lower at about 10% (RA Eeles et al., in
preparation). In some, at least, of the families which do not
apparently have mutations in the p53 gene itself, there is
evidence that p53 is deregulated due to an as yet unknown
germline defect (Barnes et al., 1992; MacGeoch et al., 1995).
In these particular families immunohistochemistry with anti-
p53 antibodies reveals high levels of stabilised p53 protein in
normal tissues of affected individuals. In this study we have
compared the response to DNA damage, of stimulated and
resting peripheral blood lymphocytes (PBLs) from eight nor-
mal individuals, three individuals with a mutation of the p53
gene and three individuals from two separate families in
which no mutation of this gene has been found but in which
constitutional deregulation of p53 is apparent by immunohis-DNAdamage response in PBL from cancer-pronesubject
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tochemistry. For simplicity the six subjects are referred to as
belonging to C-P families.
The questions we have attempted to answer are:
(1) In response to DNA damage, do PBLs from C-P individ-
uals exhibit any differences, in terms of cell cycle arrest(s)
and/or apoptosis, compared with cells from normal indi-
viduals?
(2) Are there any differences between the response in C-P
individuals with p53 gene mutations compared to those
C-P patients who apparently lack such a mutation?
(3) If differences in cell cycle progression delay(s) or apop-
tosis exist between normal and C-P individuals, could
such differences be used as a screening test to identify
family members who carry p53-related gene defects?
Materials and methods
Cell lines
Initial experiments were performed on three established
human tumour cell lines with known p53 status. The purpose
of these experiments was to test the hypothesis of Kasten et
al. (1991) that GI arrest was seen only in those cells with
functional wild-type p53. The three cell lines used were ZR75
(a breast carcinoma cell line with functional p53) (Bartek et
al., 1990), HeLa (a carcinoma cell line with E6 inactivated
wild-type p53) (Crook et al., 1991) and PANC1 (a pancreatic
carcinoma cell line with mutant p53) (Barton et al., 1991).
HeLa and PANC1 cells were grown as monolayers in RPMI-
1640 medium supplemented by 10% fetal calf serum. ZR75
cells were grown. also as monolayers, in Dulbecco's modified
Eagle medium supplemented with 10% serum and oestradiol
at a final concentration of 10-8 M. All experiments were
performed on exponentially growing cells. Cell lines were
irradiated with 4 Gy and samples fixed at periods up to 24 h
later.
Details ofPBL donors
Aliquots of 50 -100 ml of whole blood were obtained from
six normal individuals and two C-P individuals for the
analysis of cell cycle arrests. The two C-P patients studied for
cell cycle arrest. were both women attending the ICRF
Clinical Oncology Unit at Guy's Hospital (patients A and B
in Table I). PBLs from four additional subjects, who are
members of C-P families, were obtained for the study of the
apoptotic response; all attended the Department of Clinical
Genetics. St James's University Hospital, Leeds. In addition.
blood was also obtained from a further two normal individ-
uals from Leeds. Thus, in total. samples from eight normal
and six C-P individuals were investigated for apoptotic res-
ponse. The six C-P individuals come from five separate
families (individuals C and D are related) which meet the
criteria either of classical LFS or LFL families (Birch et al..
1994). For details of the six C-P subjects see Table I. The
eight normal individuals were unrelated to each other and
were all members of laboratory staff, none had a history of
unusual cancer incidence.
Separation and culture ofPBL
Stimulated PBL At Guy's and St Thomas' Hospitals. whole
blood was collected in 50 ml heparinised falcon tubes (Becton
Dickinson) and taken within 1 h to the laboratory for separa-
tion of mononuclear cells. Blood samples obtained from
Leeds were collected in similar tubes containing EDTA and
sent the same day to London. After removal of plasma.
PBLs were separated by centrifugation on Lymphoprep
(Nycomed Pharma, Norway) at 1700 r.p.m. for 30 min. PBLs
were collected from the surface of the lymphoprep and
diluted to a volume of 25 ml with sterile saline. Suspensions
were centrifuged at 1000 r.p.m. for 10 minm the cell pellet
isolated and resuspended in 10 ml of RPMI-1640 (Gibco.
Paisley. UK) containing 10% serum plus antibiotics. Cell
concentrations were determined using a Coulter Counter
(Coulter. Coulter Electronics. Fl. USA) and the concentra-
tion adjusted by addition of medium so as to achieve a
concentration of 5 x 105 PBL ml-'. An aliquot of IO ml of
this suspension was added to a series of Falcon T25 tissue
culture flasks (Becton Dickinson). To each flask was added
1.1 ml of phytohaemagglutinin (PHA-P) (Sigma. Poole.
Dorset. UK) at a concentration of 20 mg ml-'. Flasks were
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Table I Details of patients involved in the study
Subject Details of malignancy, age at onset
(location) (vears) p53 status
A (G) 1. Ductal carcinoma in situ of right Three base pair deletion at codon 151
breast (24) in exon 5 resulting in loss of
2. GIII infiltrating ductal carcinoma of proline (Eeles et al., 1995).
right breast (26) Stabilised p53 protein in malignant
3. Malignant fibrous histiocytoma of and benign tissues similar to. but
right flank (26) less extensive, than patient B
B (G) 1. GIII infiltrating ductal carcinoma of No mutation found in the entire
left breast (34) coding region of the p53 gene.
2. Leiomyosarcoma (40) Extensive immunohistochemical
3. Ductal carcinoma in situ of right evidence of stabilised p53 protein in
breast (41) malignant and benign tissues
4. GIII infiltrating ductal carcinoma of (Barnes et al.. 1992)
right breast (48)
C (L) 1. Carcinoma cervix (36) No mutation found in exons (1-11)
2. Carcinoma of breast (41) (RA Eeeles, personal communication).
3. Carcinoma of breast (43) Strong staining of p53 in normal
tissues (MacGeoch et al.. 1995)
D (L) None Not known. No tissue available for
p53 staining
E (L) 1. Tumour of adrenal cortex (2) Mutation at codon 248 CGG-*TGG
2. Carcinoma of breast (29) (Arg-*Trp) (Birch et al.. 1994)
F (L) 1. Carcinoma breast (43) Mutation found at codon 245 in exon
2. Carcinoma breast (45) 7 GGC-*AGC (Gly-*Ser)
(MacGeoch et al., 1995)
G. Guy's Hospital; L, Leeds. Individuals C and D are from the same family, all other subjects are
unrelated. Further information on the families can be obtained from the quoted references and if
desired by request from the authors. None of these C-P individuals had received either chemo- or
radiotherapy for a minimum of 4 years prior to the performance of these experiments; three of the
five patients had never received such therapy.DNAdanipg.rpsim POL k cimwrpuw sujet
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then placed upright at 37C in a 5% carbon dioxide atmo-
sphere. Experiments were begun 70 h after PHA stimulation.
Unstimulated PBL Blood was collected, separated and
diluted as described above. The cells were cultured in the
same manner for 70 h without the addition of PHA. Cells
were irradiated or mock treated at this time and cultured for
a further 24 h, at which time they were fixed in 70% ethanol.
Irradiation procedure
Irradiation was carried out using a Gammacell 1000 Elite
(Nordion International) containing a caesium 137 source and
with a dose rate of 858 cGy per minute. Preliminary
experiments on both tissue culture cells and PBLs established
that 4 Gy was a suitable radiation dose to achieve substantial
cell cycle arrest(s), with only slight immediate lethality. Doses
of 4 Gy were subsequently used in all further experiments.
Control (unirradiated) flasks ofcells were treated in an other-
wise identical manner to those being irradiated (being placed
next to the cell irradiator during delivery of 4 Gy to the
irradiated flasks).
Bromodeoxyuridine (BrdUrd) labellingprocedures
Cell lines Initial experiments on established cell lines were
performed using a protocol similar to that used by Kastan et
al. (1991). In these experiments, cells were irradiated at time
zero and BrdUrd (1OgM) was added to the culture medium
30min before fixation. Aliquots of cells were fixed at inter-
vals up to 24 h after irradiation.
Stimdated PBL Subsequently a BrdUrd protocol was used
which allows a better visualisation of cell cycle arrest(s). In
a
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this case BrdUrd (2.5 tM) was added to cells for 30min
immediately after treatment (4 Gy or mock irradiation) and
then removed by washing. Incubation was then continued in
BrdUrd-free medium and cell samples fixed at various time
intervals up to 24 h after treatment (typical time points were
3, 5, 8, 13, 18 and 24h). All experiments with PBLs were
performed using this labelling protocol. Cells were fixed in
70% ethanol.
Analyticalflow cytometry
Cell lines and stimulated PBL Cells were stained for simul-
taneous determination of BrdUrd incorporation and DNA
content as described previously (Wilson et al., 1992). Briefly,
after removal of ethanol, 2 x 106 cell aliquots were subjected
to DNA denaturation by exposure to 0.1 M hydrochloric acid
at 37C for 10 min. After washing, cells were incubated with
20 tll of a mouse anti-BrdUrd monoclonal antibody (Becton
Dickinson) in a total volume of 100gl for 30 min. After
further washes cell aliquots were incubated with 10 tll of a
fluorescein isothirocyanate (FITC)-linked second stage rabbit
anti-mouse monoclonal antibody (Dako) once again in a
total volume of 100lil for 30min. After washes, cells were
stained for DNA content by addition of propidium iodide
(PI-Sigma) at a final concentration of 50jug ml-I and RNAse
(Sigma) at a final concentration of 250pgml-I in a volume
of 1 ml. Cells were stained for a minimum of 30 min prior to
measurement of green fluorescence (BrdUrd), red
fluorescence (PI), forward and 90g light scatter on a Becton
Dickinson, FACScan. At least 10 000 cells per sample were
scanned and data were stored in list mode prior to analysis
using LYSIS H software. Doublet discrmination using pulse
area-width analysis on the PI signal was used to remove cell
clumps from the analysis.
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Figwe 1 (a) DNA histogram for unirmdiated ZR75 cells. (b) Data for the same cells 9 h after 4 Gy irradiation. A clear G2 arrest
is apparent in the irradiated cells as well as a G, arrest demonstrated by the almost complete absence- of S-phase cells. (c and d)
Equivalent data for HeLa cells: in this case a G2 arrest is again apparent but there is no evidence of a G, arrest; the imdiated cells
have a normal level of S-phase cells. These data were confirmed by BrdUrd labelling experiments
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Measurement of the time course and extent of apoptosis was
performed, primarily by assessment of cells appearing in a
sub-G1 peak on DNA profiles. This flow cytometric method
has been described and validated in many publications (see,
for example, Ormerod et al., 1992). The appearance of a
sub-G1 peak is due to the action of specific endonucleases
which lead to DNA fragmentation in apoptotic cells (Wyllie
et al., 1984). Such DNA fragmentation generally, but not
always, accompanies apoptosis and pilot experiments demon-
strated the appearance of a sub-GI peak in normal PBLs
following irradiation. However, it is essential to confirm the
identity ofcells, in the sub-GI peak, as apoptotic by reference
to morphology. In this study this was done in two ways:
Cell sorting In order to confirm that cells in the sub-GI
peak after radiation were predominantly apoptotic, these
cells were sorted on a Becton Dickinson FACStar plus onto
glass slides. Sorting was performed on cells stained with PI
(50pgnml-') and RNAse (250 Lgml'1). Counting with a
fluorescence microscope confirmed that over 80% of cells in
the sub-GI peak were apoptotic in two samples taken after
radiation from normal individuals.
Electron microscopy Cells were pelleted and fixed in 2.5%
glutaraldehyde in Sorensen's phosphate buffer (pH 7.4), post-
fixed in 1% osmium tetroxide in the same buffer, dehydrated
through graded ethanol and embedded in Araldite. Sections
were cut on a Reichert Ultracut, stained with uranyl acetate
and lead citrate and examined in a Zeiss EM1OCR. PBLs of
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healthy appearance and apoptotic cells were counted per grid
space.
Results
Cell lines: cell cycle arrest
ZR75 cells ZR75 cells (wild-type p53) demonstrated clear
GI and G2 arrests following irradiation. As a result, in Figure
1 (a and b) the proportion of GI cells remains constant after
irradiation, whilst S-phase cells proceed into G2 where they
are arrested.
HeLa cells In contrast, HeLa cells (E6 inactivated wild-type
p53) and PANCI cells (mutant p53) failed to show a GI
arrest. Data for HeLa cells are shown in Figure 1 (c and d).
As can be seen cells continue to move out of G1 through
S-phase and into G2, where they are arrested. Data for
PANCI cells are identical to those obtained with HeLa cells.
The cell cycle arrest information for all cell lines was
confirmed with BrdUrd labelling.
PBLs: cell c)ycle arrest
With stimulated PBLs from all the individuals tested, both
normal and C-P, no evidence of a GI arrest was seen at any
time after irradiation. Typical data at 8 h after treatment are
illustrated in Figure 2 for a normal and a C-P individual. No
block of cells entering S-phase from G1 is seen in either case.
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Fure 2 (a and b) Data for PBLs, taken from a normal individual. Three days after stimulation with PHA cells were either
irradiated with 4 Gy or mock irradiated. The DNA profile in a is from mock-irradiated cells and in b for cells which have received
4 Gy. There is no evidence of a GI arrest after radiation, the cells having a normal S-phase fraction. Similar results are shown in c
and d for cells taken from a C-P patient; once again there is no evidence of a GI arrest In both cases only a modest accumulation
of cells in G, is seen after irradiation
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Only modest accumulation of cells in G2 was apparent in
both cases following irradiation. However, the bivariate plot
of DNA content and BrdUrd labelling illustrated in Figure 3,
demonstrates that cells were arrested in G2 but it would
appear that some arrested G2 cells are lost. Significant,
though variable, accumulation of cells in G2 was seen at later
times after radiation in most experiments. In Figure 3
unlabelled GI cells have clearly entered S-phase confirming
the lack of a GI arrest. This finding is confirmed by com-
parison of the cell cycle phase distributions after radiation
with controls. In the control sample illustrated in Figure 3
cell cycle distributions was GI, 70%; S-phase, 23%; G2M,
7%. As described in the legend to Figure 3, after irradiation
arrested G2 cells were lost and it is necessary to correct for
this loss to estimate changes in proportions ofGI and S cells;
this can be done using BrdUrd labelling information. Cor-
rected phase distributions 8 h after irradiation are G0, 49%;
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Fiwe 3 (a and b) Data from the same experiment as that
illustrated in a and b of Figure 2. DNA content is plotted on the
abscissa on a linear scale and BrdUrd fluorescence on the
ordinate on a log scale. It should be stressed that cells were
BrdUrd labelled at the beginning of the experiment not
immediately prior to fixation. Thus in the top panel at 8 h after
mock irradiation, most BrdUrd labelled cells have passed through
G2 and re-entered G1. (b) Results for 8 h irradiated cells are
shown; there is no evidence of a G1 arrest as unlabelled cells,
which were in GI at the time of irradiation have entered S-phase.
If G1 arrest had occurred these unlabelled cells would have been
arrested in G1 and could not have entered S-phase in the 8 h
since irradiation. However, there is evidence of a G2 arrest as few
BrdUrd-labelled cells have re-entered GI; this is despite the lack
of significant accumulation of cells in G2* It would appear from
this plot that G2 arrested cells have been lost.
S-phase, 26% and G2JM, 25%. The reduction in GI cells and
the maintenance of the S-phase fraction are entirely consis-
tent with the lack of a G, arrest.
PBLs: apoptosis
Confirmation that cells in the sub-G, peak were predominantly
apoptotic Most assessments of apoptosis in this study were
done by measunng the size of the sub-GI peak in DNA
profiles of acid denatured cells. To confirm that the sub-0I
peak did represent apoptotic cells a number of tests were
performed. These tests included light microscopic counting of
apoptotic cells in some samples and FACS sorting of cells
from the sub-0I peak in two experiments. These light micros-
copic examinations confirmed the increase in apoptotic cells
indicated by the flow cytometric data. In addition, electron
microscopy was performed on pellets of both mock
irradiated and irradiated cells obtained from one normal and
one C-P individual. Figure 4 illustrates the results of this
procedure. From the four samples illustrated in Figure 4,
counts of intact and apoptotic lymphocytes were performed
and the results compared with the flow cytometric
measurements (see Table II).
Apoptosis in stimulated PBLs In all but one case, stimulated
PBLs from normal individuals showed an increase in apop-
totic cells following irradiation. This increase became appar-
ent 8-13h after treatment and reached its peak 18-24h
after radiation. However, the extent of the increase was
extremely variable within the group of normal individuals
and seemed to be inversely related to the level of stimulation.
The lower the level of proliferation in a particular experi-
ment, the greater was the increase in apoptotic cells (Figure
5). The maximum apoptotic response was seen in un-
stimulated, irradiated PBLs.
Apoptosis in unstimulated PBLs Typical flow cytometric
data are illustrated in Figure 6; the top two panels represent
data from a normal individual, whilst the bottom two panels
show equivalent data for a C-P individual. Quantitative
results on the size of the increase in apoptotic cells for the
eight normal and six C-P individuals studied are given in
Table MII. A clear and highly significant difference is seen
(P = 0.0003) with the C-P individuals having a much reduced
apoptotic response following radiation. The abnormal apop-
totic response was seen in C-P individuals irrespective of
whether a p53 mutation had been demonstrated. The finding
of a reduced apoptotic response in subject D was surprising
because, although this individual is from a known cancer-
prone family (that of patient C-see Table I), he was not
thought to carry the defect since he had reached his seventies
without developing a malignancy.
Dicssiom
When comparing the response, to DNA damage, of
stimulated PBLs from normal and C-P individuals, no
differences were seen in terms of cell cycle arrest(s). In all
cases the expected G2 arrest was seen but no evidence of a G1
arrest was apparent in any experiment. Although it might
seem initially surprising that stimulated PBLs from normal
individuals failed to show a GI arrest, this may be related to
conformational changes in p53. A number of reports in the
Table I Comparison of E-M counting and flow cytometric
determination of apoptosis in unstimulated PBLs
Increase in sub-GI peak Increase in apoptotic
(%) lymphocytes by EM (%)a
Normal PBLs 42.0 37.1
C-P PBLs 14.0 6.5
aNB To obtain these counts an average of 877 lymphocytes per
sample were counted from two blocks.
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unirradiated PBL. (b) The same cells 24 h after 4Gy, many cells have aleady been lost by apoptosis and the cell density is reduced.
At this time about 40% of }remining lymphocytes are apoptotic (see Table II). (c) Unirradiated PBL from a C-P patient. (d) The
same cells 24 h after 4Gy, most cells appear viable but there is a small increase in apoptotic cells (see Table IT).
literature have indicated that wild-type p53 undergoes a con-
formational change in lymphocytes following stimulation by
mitogens (Milhr, 1984; Milner and Watson, 1990; Wu et al.,
1993). These studies involved the use of a panel of anti-p53
monoclonal antibodies some of which recognise the 'wild-
type' conformation and some the 'mutant' conformation of
the p53 protein. Donehower and Bradley (1993) incorporated
this type of evidence into a model for p53 conformation and
oligerrisation changes (Figure 5 in Donehower and
Bradley). It is suggested that as part of the growth
stimulatory response seen, for example in PBLs after mitogen
treatment, wild-type p53 is switched into a 'pro-
moter-mutant' conformation. Thus it could be hypothesised
that in stimulated normal PBLs GI arrest is not seen because
p53 is in this 'promoter-mutant' conformation and is func-
tionally altered.
However, a difference between the response of normal and
C-P PBLs to radiation, was apparent in terms of apoptosis.
In almost all the experiments on stimulated PBLs from nor-
mal individuals a time-dependent increase in apoptotic cells
was seen following radiation treatment. This increase was
first apparent at around 8 h after radiation and a maximum
was reached by 18-24h after treatment. In contrast there
was no increase in apoptotic cells at any time following
radiation in stimulated PBLs from the two Guy's C-P
patients. Although, an increase in apoptotic cells was usually
seen in stimulated PBLs from normal individuals, the extent
of this increase was extremely variable (see Figure 5), with an
apparent inverse correlation with the level of proliferation
achieved. Proliferative responses to PHA were, themselves,
extremely variable with S-phase fractions at 72 h after
stimulation varying from around 5% to over 30%. This
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variation in proliferative status complicated the comparison
of apoptotic response in cells from C-P and normal individ-
uals. The data are consistent with but do not prove that
apoptosis occurs only from non-proliferative cells. If it were
true. the difference in response of proliferative and non-
proliferative lymphocytes could be due to conformational
differences in p53 as discussed above. It was found that the
maximum apoptotic response was seen in unstimulated PBLs
and this enabled difficulties in the interpretation of results
due to varying proliferative activity to be avoided.
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Figure 5 The chart above illustrates the relationship between
S-phase fraction and the increase in apoptotic cells seen 24 h after
4 Gy irradiation. The six values represented by solid points are
data for unstimulated PBL, whilst the other six data points (open
symbols) represent results from a separate series of experiments
on PHA-stimulated PBL. There is a wide variation in the level of
proliferation seen in different samples following identical PHA
stimulation. A ranked correlation of all the data yielded a cor-
relation coefficient of -0.84 (P = 0.0003), whilst the same test on
the data from the stimulated samples only (open symbols)
resulted in a correlation coefficient of -0.82 (P = 0.02).
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A clear statistically significant difference was seen in the
apoptotic response of unstimulated PBLs from the C-P sub-
jects compared to that in a group of normal individuals.
Clearly caution must be exercised given the moderate number
of C-P individuals studied so far; further work is clearly
called for. However, the results are consistent with a wide
body of evidence that suggests functional p53 is required for
switching DNA-damaged cells into apoptosis (see for exam-
ple Clark et al., 1993; Lowe et al., 1993; Ryan et al.. 1993).
Although some of the C-P families appear to lack a p53
mutation, they all have p53-related defects (Table I). Three
of the C-P individuals studied come from families with pro-
ven p53 mutations (subjects A, E and F) and three are
members of C-P families apparently without p53 mutations
but with deregulation of p53 protein (individuals B. C and
D). Both of the patients and affected members of their
Table m Flow cytometric determination of the increase in
apoptotic cells, in normal and C-P individuals, following
radiation
Normal Increase in C-P Increase in
indvidua apoptosis (%o* indvidual apoptosis (o)**
1 51 A 14
2 33 B 1
3 42 C 18
4 38 D 9
5 32 E 3
6 42 F 19
7 40
8 38
Comparison * and ** P = 0.0003 (Fisher's exact test). Normal
individuals 1-6 and cancer-prone subjects A-B are from Guy's and
St Thomas' Hospitals. Normal individuals 7 -8 and cancer-prone
subjects C-F are from Leeds.
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families without p53 mutations, but with a history of malig-
nant disease (patients B and C), exhibit high levels of
stabilised, apparently wild type. p53 protein in normal cells.
something not usually seen in unperturbed cells from normal
individuals or classical LFS patients (Barnes et al., 1992).
There are insufficient data to allow any analysis of fine
differences in response between C-P patients with and with-
out a detected p53 mutation: all C-P individuals showed a
marked reduction in apoptotic reponse after DNA damage.
The clear difference in apoptotic response in unstimulated
PBLs from normal and C-P individuals, with no overlap in
the values obtained for the two groups, suggests the pos-
sibility that this response could form the basis of a screening
test for individuals who might carry p53-related defects. At-
risk relatives of C-P patients could benefit from a test to
determine whether they carry the. often unknown. inherited
defect. p53 mutations are time consuming to isolate in
Li-Fraumeni families and impossible to define in familites for
whom the underlying nature of the p53-related cancer predis-
position is not known. We suggest that a functional test of
apoptotic response could be used as a cheap and rapid
method to screen individuals for p53-related defects. Such an
assay involves only modest labour and does not require
extraction and manipulation of RNA or DNA from cells.
The utility of such a test is highlighted by individual D
(Table I); there was initial surprise that this individual
showed a reduced apoptotic response after irradiation. This
person. though from a recognised LFL family (that of
patient C - see Table I). was not thought to carry the
unknown p53-related defect. as he is over 70 years of age and
has no history of malignancy. Nevertheless. the reduced
apoptotic response seen in PBLs from this subject raises the
possibility that patient D may carry the defect exhibited in
other members of his family despite his lack of malignant
disease. It is known that a minority of Li-Fraumeni patients
(about 10%) do not develop malignancies and after age 60
the risk of malignancy in such individuals is similar to that of
normal individuals (Garber et al.. 1991: Eeles. 1993).
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